EPISODE · Apr 23, 2026 · 2 MIN
Therapeutics Stocks Q4: AI, Orphan Drugs Drive Growth
from The Daily News Now! Business
Therapeutics stocks wrapped up Q4 strong, beating revenue estimates by 7.1%. AbbVie led with a 10% Y/Y revenue increase, but stocks dipped due to lost exclusivity. Novavax saw a 66.6% revenue jump, yet shares fell. United Therapeutics stock surged 23% despite a revenue miss. Vertex Pharmaceuticals missed earnings per share, causing shares to fall. Halozyme Therapeutics revenue soared, but other misses tanked stocks. The sector holds firm amid earnings noise, setting up for a pivotal 2026 with AI innovations and regulatory hurdles. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e6461af7574174ce
NOW PLAYING
Therapeutics Stocks Q4: AI, Orphan Drugs Drive Growth
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m